TRICIDA INC has a total of 97 patent applications. It increased the IP activity by 11.0%. Its first patent ever was published in 2014. It filed its patents most often in United States, EPO (European Patent Office) and WIPO (World Intellectual Property Organization). Its main competitors in its focus markets pharmaceuticals, macromolecular chemistry and polymers and machines are OCCLUGEL, OLIGASIS and FERRUTI PAOLO.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 15 | |
#2 | EPO (European Patent Office) | 12 | |
#3 | WIPO (World Intellectual Property Organization) | 10 | |
#4 | Israel | 8 | |
#5 | Australia | 7 | |
#6 | Canada | 6 | |
#7 | China | 5 | |
#8 | Mexico | 5 | |
#9 | Hong Kong | 4 | |
#10 | Hungary | 4 | |
#11 | Serbia | 4 | |
#12 | Brazil | 3 | |
#13 | Japan | 3 | |
#14 | Republic of Korea | 3 | |
#15 | Singapore | 3 | |
#16 | Morocco | 2 | |
#17 | Montenegro | 1 | |
#18 | Russian Federation | 1 | |
#19 | Taiwan | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Macromolecular chemistry and polymers | |
#3 | Machines |
# | Name | Total Patents |
---|---|---|
#1 | Klaerner Gerrit | 78 |
#2 | Buysse Jerry M | 67 |
#3 | Tabakman Scott M | 58 |
#4 | Kierstead Paul H | 58 |
#5 | Biyani Kalpesh N | 58 |
#6 | Connor Eric F | 58 |
#7 | Nguyen Son H | 58 |
#8 | Kade Matthew J | 58 |
#9 | Gbur Randi K | 57 |
#10 | Cope Michael J | 57 |
Publication | Filing date | Title |
---|---|---|
US2020306209A1 | Method of treating acid-base disorders | |
WO2019236639A1 | Method of treating acid-base disorders | |
EP3740201A1 | Method of treating acid-base disorders | |
WO2019236124A1 | Method of treating acid-base disorders | |
EP3703707A1 | Method of treating acid-base disorders | |
WO2019090176A1 | Compositions for and method of treating acid-base disorders | |
US10934380B1 | Crosslinked poly(allylamine) polymer pharmaceutical compositions | |
AU2017261337A1 | Compositions for and method of treating acid-base disorders | |
MA48486B1 | Proton-binding polymers for oral administration | |
CN105377270A | Proton-binding polymers for oral administration |